5
Registered trials
2
Recruiting
2
Completed trials
1
Countries active
13
Unique IMPs
100%
Results reported
100%
2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
Top IMPs
(4R)-1-[(3-(11C)METHYLPYRIDIN-4-YL)METHYL]-4-(3,4,5-TRIFLUOROPHENYL)PYRROLIDIN-2-ONE
1
(N-METHYL-(11C))2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE
1
2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE
1
ACETYLCYSTEINE
1
ALDESLEUKIN
1
ATOMOXETINE
1
CALCIUM FOLINATE
1
CILOSTAZOL
1
CYANOCOBALAMIN
1
N,N-DIETHYL-2-(2-(4-(2[(18)F]-FLUOROETHOXY)PHENYL)5,7DIMETHYLPYRAZOLO[1,5A]PYRIMIDIN-3-YL)ACETAMIDE
1
OMEGA-3-ACID ETHYL ESTERS 90
1
SODIUM CHLORIDE
1
All trials
5 totalShowing 1–5 of 5 trials